Well, those good folks are the real experts. They KNOW.
In fact, right after the FDA renders its first approval of blarcamesine for any one of the three indications currently on the table, we will be awed with their postings on how the FDA was "so wrong."
As readers here have already, we'll all need to learn from the naysaying experts who so effectively post here.
I also think the next big hit for AVXL will be the well written/compelling Peer reviewed doc which IMO, will put the AVXL MOA and TRIFECTA results at the top of the FDA list of , "Things to get DONE-ASAP."